Cambridge, Massachusetts-based Sense, a home intelligence platform, has raised $15 million in Series A funding. Shell Technology Ventures and Energy Impact Partners led the round with participation from Capricorn Investment Group, Prelude Ventures, CRV, Bolt and iRobot Ventures.
1 min read · 05 January 2017
Massachusetts-based Zagster, a provider of private and public-private bike-sharing systems, has raised $10 million in Series B funding. Edison Partners led the round.
3 min read · 05 January 2017
French energy supplier ekWateur has secured 2 million euros in funding. The investors were Aster, BNP Paribas Développement and Bouygues Telecom Initiatives.
5 min read · 05 January 2017
New York-based Payfone, a provider of mobile identity authentication for digital channels, has raised $23.5 million in Series E financing. BlueCross BlueShield Venture Partners and Andrew Prozes led the round with participation from Strauss Zelnick, Maclab Development Group and Transaction Network Services, RRE Ventures, Opus Capital, Relay Ventures, Early Warning Services, American Express Ventures, Verizon Ventures and Rogers Venture Partners.
3 min read · 05 January 2017
Bardy Diagnostics Inc, a developer of a cardiac monitor and arrhythmia detection device, has secured an undisclosed amount of funding. The investors were SV Life Sciences Advisers, Health Enterprise Partners, Ascension Ventures and Square 1 Bank.
1 min read · 05 January 2017
San Francisco-based personal radio app Otto Radio has secured an undisclosed amount of funding. The investor was Samsung NEXT, Samsung Group's venture capital arm.
1 min read · 05 January 2017
Silicon Valley-based Reputation.com, a provider of online reputation management technology and services, has raised a total of $20 million. The investors include Ascension Ventures, August Capital, Bessemer Venture Partners, Icon Ventures, Kleiner Perkins and Focus Ventures.
1 min read · 05 January 2017
Florida-based Jupiter Orphan Therapeutics Inc, which is developing therapies for rare diseases linked to single gene deficiencies, has secured $2 million in financing. The investor is Tarnagulla Ventures.
1 min read · 05 January 2017
UK-based NeRRe Therapeutics, a developer of neurokinin receptor antagonists that treat conditions caused by neuronal hypersensitivity, has secured 23 million pounds in Series B funding. The investors were Fountain Healthcare Partners, Forbion Capital Partners, OrbiMed, Advent Life Sciences and Novo A/S.
1 min read · 05 January 2017
South San Francisco-based BlackThorn Therapeutics, a treatment developer for neurobehavioral disorders, has raised an additional $14 million in Series A funding. The investors in this round were GV and Biomatics Capital.
1 min read · 05 January 2017
